NCT01754987View on ClinicalTrials.gov

A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Metastatic Hepatocellular CarcinomaAdvanced Liver Cancer
Interventions
DRUG

Ascorbic Acid + Sorafenib

DRUG

Sorafenib

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT01754987 - A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective | Biotech Hunter | Biotech Hunter